Back to search
p47
Clinical trial pipeline · Data from ClinicalTrials.gov
See which p47 trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which p47 trials you may qualify forThis is an open-label, first-in-human study designed to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor activity of selperca…
Background: Chronic granulomatous disease (CGD) is a genetic disorder. People with CGD are missing a gene that affects their white blood cells. White cells are…